Miss Emma Scholefield
Technician
Strathclyde Institute of Pharmacy and Biomedical Sciences
Back to staff profile
Publications
- P13.06. A evaluation of BBB permeable WEE1 and CHK1 inhibitors in combination with standard of care for the treatment of Glioblastoma
- Scholefield E L, Gomez-Roman N
- Neuro-Oncology Vol 26, pp. v72-v72 (2024)
- https://doi.org/10.1093/neuonc/noae144.239
- Methylthioadenosine phosphorylase genomic loss in advanced gastrointestinal cancers
- Ngoi Natalie YL, Tang Tin-Yun, Gaspar Catia F, Pavlick Dean C, Buchold Gregory M, Scholefield Emma L, Parimi Vamsi, Huang Richard SP, Janovitz Tyler, Danziger Natalie, Levy Mia A, Pant Shubham, De Armas Anaemy Danner, Kumpula David, Ross Jeffrey S, Javle Milind, Rodon Ahnert Jordi
- The Oncologist Vol 29, pp. 493-503 (2024)
- https://doi.org/10.1093/oncolo/oyae011
- Evaluating the enhancement of cell kill by radiation therapy through novel wee1 inhibitors with improved brain permeability in the treatment of glioblastoma
- Scholefield Emma, Gomez-Roman Natividad
- Cancer Research UK - Association for Radiation Research Conference (2023)
Back to staff profile
Projects
- Investigating Commercial and Novel Wee1 and Chk1 Inhibitors with for the Treatment of Glioblastoma
- Scholefield, Emma Laura (Post Grad Student) Gomez-Roman, Natividad (Principal Investigator)
- 01-Jan-2022 - 30-Jan-2025
Back to staff profile
Contact
Miss
Emma
Scholefield
Technician
Strathclyde Institute of Pharmacy and Biomedical Sciences
Email: emma.scholefield@strath.ac.uk
Tel: Unlisted